Search Results

There are 9361 results for: content related to: Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma

  1. MDM2 gene amplification in colorectal cancer is associated with disease progression at the primary site, but inversely correlated with distant metastasis

    Genes, Chromosomes and Cancer

    Volume 49, Issue 7, July 2010, Pages: 620–629, Nobuhiro Sugano, Tetsuji Suda, Ten-I Godai, Kazuhito Tsuchida, Manabu Shiozawa, Hironobu Sekiguchi, Mitsuyo Yoshihara, Shoichi Matsukuma, Yuji Sakuma, Eiju Tsuchiya, Yoichi Kameda, Makoto Akaike and Yohei Miyagi

    Version of Record online : 13 APR 2010, DOI: 10.1002/gcc.20774

  2. You have free access to this content
    Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome

    International Journal of Cancer

    Volume 132, Issue 9, 1 May 2013, Pages: 2044–2055, Maral Jamshidi, Marjanka K. Schmidt, Thilo Dörk, Montserrat Garcia-Closas, Tuomas Heikkinen, Sten Cornelissen, Alexandra J. van den Broek, Peter Schürmann, Andreas Meyer, Tjoung-Won Park-Simon, Jonine Figueroa, Mark Sherman, Jolanta Lissowska, Garrett Teoh Hor Keong, Astrid Irwanto, Marko Laakso, Sampsa Hautaniemi, Kristiina Aittomäki, Carl Blomqvist, Jianjun Liu and Heli Nevanlinna

    Version of Record online : 25 OCT 2012, DOI: 10.1002/ijc.27884

  3. You have full text access to this OnlineOpen article
    Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon

    International Journal of Cancer

    Volume 137, Issue 1, 1 July 2015, Pages: 96–103, Liv B. Gansmo, Stian Knappskog, Pål Romundstad, Kristian Hveem, Lars Vatten and Per E. Lønning

    Version of Record online : 10 DEC 2014, DOI: 10.1002/ijc.29358

  4. You have free access to this content
    The Mdm Network and Its Regulation of p53 Activities: A Rheostat of Cancer Risk

    Human Mutation

    Volume 35, Issue 6, June 2014, Pages: 728–737, Christine M. Eischen and Guillermina Lozano

    Version of Record online : 6 MAR 2014, DOI: 10.1002/humu.22524

  5. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck

    Molecular Carcinogenesis

    Volume 50, Issue 9, September 2011, Pages: 697–706, Hongping Yu, Yu-jing Huang, Zhensheng Liu, Li-E Wang, Guojun Li, Erich M. Sturgis, David G. Johnson and Qingyi Wei

    Version of Record online : 7 JUN 2011, DOI: 10.1002/mc.20806

  6. Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma

    Pediatric Blood & Cancer

    Volume 61, Issue 10, October 2014, Pages: 1867–1870, Ali Rihani, Tom Van Maerken, Bram De Wilde, Fjoralba Zeka, Geneviève Laureys, Koen Norga, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes H. Schulte, Angelika Eggert, Raymond L. Stallings, Frank Speleman and Jo Vandesompele

    Version of Record online : 4 JAN 2014, DOI: 10.1002/pbc.24927

  7. TP53 mutations and MDM2SNP309 identify subgroups of AML patients with impaired outcome

    European Journal of Haematology

    Volume 94, Issue 4, April 2015, Pages: 355–362, Ingrid Jakobsen Falk, Kerstin Willander, Roza Chaireti, Johan Lund, Hareth Nahi, Monica Hermanson, Henrik Gréen, Kourosh Lotfi and Peter Söderkvist

    Version of Record online : 1 OCT 2014, DOI: 10.1111/ejh.12438

  8. MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma

    Pediatric Blood & Cancer

    Volume 55, Issue 2, August 2010, Pages: 267–272, Stefano Parodi, Chiara Perfumo, Alberto Garaventa, Alberto Inga, Katia Mazzocco, Raffaella Defferrari, Gian Paolo Tonini, Gilberto Fronza and Riccardo Haupt

    Version of Record online : 15 MAR 2010, DOI: 10.1002/pbc.22477

  9. MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma

    Pediatric Blood & Cancer

    Volume 53, Issue 4, October 2009, Pages: 576–583, Chiara Perfumo, Stefano Parodi, Katia Mazzocco, Raffaella Defferrari, Alberto Inga, Giovanna Bianchi Scarrà, Paola Ghiorzo, Riccardo Haupt, Gian Paolo Tonini and Gilberto Fronza

    Version of Record online : 12 JUN 2009, DOI: 10.1002/pbc.22132

  10. Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility

    Diseases of the Esophagus

    Volume 28, Issue 6, August/September 2015, Pages: 593–601, B. Chen, M.-M. Xiong and X.-L. Meng

    Version of Record online : 20 MAY 2014, DOI: 10.1111/dote.12240

  11. Common Polymorphisms in the MDM2 and TP53 Genes and the Relationship between TP53 Mutations and Patient Outcomes in Glioblastomas

    Brain Pathology

    Volume 19, Issue 2, April 2009, Pages: 188–194, Izabela Zawlik, Daisuke Kita, Salvatore Vaccarella, Michel Mittelbronn, Silvia Franceschi and Hiroko Ohgaki

    Version of Record online : 6 MAY 2008, DOI: 10.1111/j.1750-3639.2008.00170.x

  12. You have free access to this content
    MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients

    International Journal of Cancer

    Volume 120, Issue 3, 1 February 2007, Pages: 563–565, Bente A. Talseth, Cliff Meldrum, Janina Suchy, Grzegroz Kurzawski, Jan Lubinski and Rodney J. Scott

    Version of Record online : 9 NOV 2006, DOI: 10.1002/ijc.22339

  13. You have free access to this content
    Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer

    Cancer

    Volume 113, Issue 4, 15 August 2008, Pages: 799–807, Ji-Youn Han, Geon Kook Lee, Dae Ho Jang, Sung Young Lee and Jin Soo Lee

    Version of Record online : 10 JUL 2008, DOI: 10.1002/cncr.23668

  14. You have full text access to this Open Access content
    Association of TP53 and MDM2 polymorphisms with survival in bladder cancer patients treated with chemoradiotherapy

    Cancer Science

    Volume 100, Issue 12, December 2009, Pages: 2376–2382, Asano Shinohara, Shigeru Sakano, Yuji Hinoda, Jun Nishijima, Yoshihisa Kawai, Taku Misumi, Kazuhiro Nagao, Takahiko Hara and Hideyasu Matsuyama

    Version of Record online : 27 AUG 2009, DOI: 10.1111/j.1349-7006.2009.01331.x

  15. You have free access to this content
    Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: A meta-analysis

    International Journal of Urology

    Volume 19, Issue 10, October 2012, Pages: 914–920, Guoyuan Liu, Deke Jiang, Suqin Shen and Long Yu

    Version of Record online : 21 JUN 2012, DOI: 10.1111/j.1442-2042.2012.03067.x

  16. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 3, June 2012, Pages: 438–443, Ali A. Alshatwi, Tarique N. Hasan, Gowhar Shafi, Mohammed A. Alsaif, Amal A. Al-Hazzani and Adulaziz A. Alsaif

    Version of Record online : 11 APR 2011, DOI: 10.1111/j.1472-8206.2011.00939.x

  17. MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese

    Molecular Carcinogenesis

    Volume 50, Issue 6, June 2011, Pages: 433–438, Jing Dong, Binhui Ren, Zhibin Hu, Jiaping Chen, Lingmin Hu, Juncheng Dai, Guangfu Jin, Lin Xu and Hongbing Shen

    Version of Record online : 25 JAN 2011, DOI: 10.1002/mc.20727

  18. You have full text access to this OnlineOpen article
    Mouse double minute-2 homolog (MDM2)-rs2279744 polymorphism associated with lung cancer risk in a Northeastern Chinese population

    Thoracic Cancer

    Volume 6, Issue 1, January 2015, Pages: 91–96, Xu Wang, Lina Jin, Jiuwei Cui, Kewei Ma, Xiao Chen and Wei Li

    Version of Record online : 7 JAN 2015, DOI: 10.1111/1759-7714.12153

  19. You have full text access to this OnlineOpen article
    MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk

    Cancer Medicine

    Volume 4, Issue 12, December 2015, Pages: 1901–1907, Liv B. Gansmo, Pål Romundstad, Einar Birkeland, Kristian Hveem, Lars Vatten, Stian Knappskog and Per Eystein Lønning

    Version of Record online : 16 OCT 2015, DOI: 10.1002/cam4.555

  20. You have free access to this content
    Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population

    International Journal of Cancer

    Volume 118, Issue 5, 1 March 2006, Pages: 1275–1278, Zhibin Hu, Hongxia Ma, Daru Lu, Ji Qian, Jiannong Zhou, Yijiang Chen, Lin Xu, Xinru Wang, Qingyi Wei and Hongbing Shen

    Version of Record online : 8 SEP 2005, DOI: 10.1002/ijc.21463